# A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

> **NCT00607308** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 20 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **BIOLOGICAL:** PF-04360365
- **BIOLOGICAL:** PF-04360365
- **BIOLOGICAL:** PF-04360365
- **BIOLOGICAL:** PF-04360365
- **DRUG:** Placebo
- **BIOLOGICAL:** PF-04360365

## Key facts

- **NCT ID:** NCT00607308
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2010-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00607308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00607308, "A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00607308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*